Search results

Skip to results

Area of interest

Area of interest

Type

Type

Status

Status

Last updated

Last updated

Guidance programme

Advice programme

Showing 2146 to 2160 of 9102 results

  1. Deep Brain Stimulation for Alzheimer

    Topic prioritisation

    Interventional procedures guidance
    Topic prioritisation

  2. Radiofrequency denervation for OA shoulder pain

    Topic prioritisation

    Interventional procedures guidance
    Topic prioritisation

  3. Hip resurfacing for hip arthritis

    Topic prioritisation

    Interventional procedures guidance
    Topic prioritisation

  4. Dermal allograft augmentation in proximal humerus fracture fixation

    Topic prioritisation

    Interventional procedures guidance
    Topic prioritisation

  5. Arthrosamid for symptomatic treatment of knee osteoarthritis

    Topic prioritisation

    Medical technologies guidance
    Topic prioritisation

  6. Glucarpidase for reducing toxic plasma methotrexate levels in people aged 28 days and over [TSID10761]

    Topic prioritisation

    Technology appraisal guidance
    Topic prioritisation

  7. Bardoxolone methyl for treating chronic kidney disease in people 12 years and over with Alport syndrome [TSID9998]

    Topic prioritisation

    Technology appraisal guidance
    Topic prioritisation

  8. DV7103 for treating cystinuria in people 6 months and over [TSID10438]

    Topic prioritisation

    Technology appraisal guidance
    Topic prioritisation

  9. Cytokine adsorption technologies for treating respiratory failure in people with COVID-19

    Topic prioritisation

    Medical technologies guidance
    Topic prioritisation

  10. MolecuLight i:X for wound imaging

    Topic prioritisation

    Medical technologies guidance
    Topic prioritisation

  11. Moor LDLS-BI for assessing burn depth and healing potential in children and adults

    Topic prioritisation

    Medical technologies guidance
    Topic prioritisation

  12. Lurbinectedin with atezolizumab for maintenance treatment of extensive-stage small-cell lung cancer [ID6526]

    In development Reference number: GID-TA11502 Expected publication date:  02 December 2026

    Technology appraisal guidance
    In development

  13. Remibrutinib for treating chronic spontaneous urticaria inadequately controlled by H1-antihistamines in people 12 to 17 years [ID6649]

    Awaiting development Reference number: GID-TA11861 Expected publication date: TBC

    Technology appraisal guidance
    Awaiting development

  14. Indoor air quality at home

    In development Reference number: GID-QS10113 Expected publication date: TBC

    Quality standard
    In development

  15. Children and young people with disabilities and severe complex needs: integrated health and social care support

    Awaiting development Reference number: GID-QS10146 Expected publication date: TBC

    Quality standard
    Awaiting development